Principal Investigator
Overview
Body Locations and Systems
Diagnosis and Therapy
Disorders and Conditions
ClinicalTrials.gov#
NCT06388564
Status
Recruiting
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Mara Westendorp, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the safety, tolerability and preliminary activity of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with chronic graft-versus-host disease.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Body Locations and Systems
Diagnosis and Therapy
Disorders and Conditions
ClinicalTrials.gov#
NCT06388564
Status
Recruiting
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Mara Westendorp, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the safety, tolerability and preliminary activity of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with chronic graft-versus-host disease.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
